Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Pens SNP-Genotyping Deal With J&J’s R&D Group

NEW YORK (GenomeWeb News) - Illumina today said it will develop custom SNP content for a multi-sample Sentrix BeadChip for Johnson & Johnson Pharmaceutical Research & Development.
 
The BeadChip platform enables researchers to analyze 12 samples and as many as 60,000 SNPs per sample on a single BeadChip. Illumina expects to use its Infinium assay to genotype "thousands" of samples provided by J&JPRD.
 
Financial details were not disclosed.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.